Lyell Immunopharma (LYEL) Other Non-Current Assets (2019 - 2026)

Lyell Immunopharma's Other Non-Current Assets history runs 8 years deep, the most recent figure standing at $1.6 million for Q1 2026.

• In Q1 2026, Other Non-Current Assets fell 6.04% year-over-year to $1.6 million; the TTM figure through Mar 2026 stood at $1.6 million (down 6.04% YoY), while the FY2025 annual figure was $1.6 million, down 6.21% from the prior year.
• Other Non-Current Assets came in at $1.6 million for Q1 2026 at Lyell Immunopharma, roughly flat from $1.6 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $1.7 million in Q4 2024 to a low of $279000.0 in Q1 2022.
• A 5-year average of $754470.6 and a median of $286000.0 in 2024 frame the typical range for Other Non-Current Assets.
• Across the five-year window, Other Non-Current Assets sank 40.13% in 2022 and jumped 495.07% in 2024, its largest moves.
• Lyell Immunopharma's Other Non-Current Assets stood at $280000.0 in 2022, then advanced by 1.43% to $284000.0 in 2023, then surged by 495.07% to $1.7 million in 2024, then declined by 6.21% to $1.6 million in 2025, then grew by 0.06% to $1.6 million in 2026.
• According to Business Quant data, Other Non-Current Assets over the past three periods registered $1.6 million, $1.6 million, and $1.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison